Glucocorticoids Regulation of FosB/ΔFosB Expression Induced by Chronic Opiate Exposure in the Brain Stress System

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  García Pérez, Daniel ^a   Laorden, M Luisa ^a   Milanés, M Victoria ^a   Núñez, Cristina ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN STRESS HORMONE; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; MORPHINE; PRODYNORPHIN; STRESS HORMONE; TRANSCRIPTION FACTOR DELTA FOSB; TRANSCRIPTION FACTOR FOSB; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADAPTATION; ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STRESS SYSTEM; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; HORMONAL REGULATION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; LONG TERM EXPOSURE; MALE; MORPHINE ADDICTION; NONHUMAN; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; SOLITARY TRACT NUCLEUS; STRIA TERMINALIS;

ADRENALECTOMY; AMYGDALA; ANIMALS; CORTICOSTERONE; ENKEPHALINS; GENE EXPRESSION REGULATION; MALE; MORPHINE; NEURONS; NUCLEUS ACCUMBENS; OPIOID-RELATED DISORDERS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SEPTAL NUCLEI; SOLITARY NUCLEUS;

RATTUS;

EID: 84869814815     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050264     Document Type: Article

References (60)

1. Volkow ND, Skolnick P, (2012) New Medications for Substance Use Disorders: Challenges and Opportunities. Neuropsychopharmacology 37: 290-292.
2. Robison AJ, Nestler EJ, (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12: 623-637.
3. Hutchison ER, Okun E, Mattson MP, (2009) The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration and Repair. Neuromolecular Med 11: 153-161.
4. Li MD, van der Vaart AD, (2011) MicroRNAs in addiction: adaptation's middlemen? Mol Psychiatry 16: 1159-1168.
5. Mumberg D, Lucibello FC, Schuermann M, Muller R, (1991) Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev 5: 1212-1223.
6. Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler EJ, (1997) Chronic Fos-Related Antigens: Stable Variants of ΔFosB Induced in Brain by Chronic Treatments. J Neurosci 17: 4933-4941.
7. Moratalla R, Elibol B, Vallejo M, Graybiel AM, (1996) Network-Level Changes in Expression of Inducible Fos-Jun Proteins in the Striatum during Chronic Cocaine Treatment and Withdrawal. Neuron 17: 147-156.
8. Chao J, Nestler EJ, (2004) Molecular Neurobiology of Drug Addiction. Annual Review of Medicine 55: 113-132.
9. Muschamp JW, Nemeth CL, Robison AJ, Nestler EJ, Carlezon J, (2012) ΔFosB Enhances the Rewarding Effects of Cocaine While Reducing the Pro-Depressive Effects of the Kappa-Opioid Receptor Agonist U50488. Biological Psychiatry 71: 44-50.
10. Gago B, Suárez-Boomgaard D, Fuxe K, Brené S, Reina-Sánchez MD, et al. (2011) Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation. Brain Res 1407: 47-61.
11. Kaplan GB, Leite-Morris KA, Fan WY, Young AJ, Guy MD, (2011) Opiate Sensitization Induces FosB/ΔFosB Expression in Prefrontal Cortical, Striatal and Amygdala Brain Regions. PLoS ONE 6: e23574.
12. Nye HE, Nestler EJ, (1996) Induction of chronic fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol 49: 636-645.
13. McClung CA, Nestler EJ, Zachariou V, (2005) Regulation of Gene Expression by Chronic Morphine and Morphine Withdrawal in the Locus Ceruleus and Ventral Tegmental Area. J Neurosci 25: 6005-6015.
14. Núñez C, Martín F, Földes A, Laorden ML, Kovács KJ, et al. (2010) Induction of FosB/ΔFosB in the brain stress system-related structures during morphine dependence and withdrawal. Journal of Neurochemistry 114: 475-487.
15. Perrotti LI, Hadeishi Y, Ulery PG, Barrot M, Monteggia L, et al. (2004) Induction of ΔFosB in Reward-Related Brain Structures after Chronic Stress. J Neurosci 24: 10594-10602.
16. Vialou V, Robison AJ, LaPlant QC, Covington HE, Dietz DM, et al. (2010) ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 13: 745-752.
17. Ambroggi FC, Turiault M, Milet A, Deroche-Gamonet V, Parnaudeau S, et al. (2009) Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking. Nat Neurosci 12: 247-249.
18. Sinha R, (2008) Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141: 105-130.
19. Koob GF, Volkow ND, (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
20. Koob G, Kreek MJ, (2007) Stress, Dysregulation of Drug Reward Pathways, and the Transition to Drug Dependence. Am J Psychiatry 164: 1149-1159.
21. Koob GF, Le Moal M, (2008) Neurobiological mechanisms for opponent motivational processes in addiction. Phil Trans R Soc B 363: 3113-3123.
22. Koob GF, (2006) The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101: 23-30.
23. Carrasco GA, Van de Kar LD, (2003) Neuroendocrine pharmacology of stress. European Journal of Pharmacology 463: 235-272.
24. Piazza PV, Le Moal M, (1997) Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Research Reviews 25: 359-372.
25. Cleck JN, Blendy JA, (2008) Making a bad thing worse: adverse effects of stress on drug addiction. J Clin Invest 118: 454-461.
26. Goodman A, (2008) Neurobiology of addiction. An integrated review. Biochem Pharmacol 75: 266-322.
27. Dunn AJ, Swiergiel AH, (2008) The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems. European Journal of Pharmacology 583: 186-193.
28. Koob GF, Le Moal M, (2008) Addiction and the brain antireward system. Ann Rev Physiol 59: 29-53.
29. Núñez C, Földes A, Pérez-Flores D, García-Borrón JC, Laorden ML, et al. (2009) Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase (TH) mRNA expression, phosphorylation and enzyme activity in the nucleus of the solitary tract (NTS-A2) during morphine withdrawal. Endocrinology 150: 3118-3127.
30. Navarro-Zaragoza J, Hidalgo JM, Laorden ML, Milanés MV (2012) Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal. Br J Pharmacol DOI: 10.1111/j.1476-5381.2012.01918.x.
31. Renthal W, Nestler EJ, (2008) Epigenetic mechanisms in drug addiction. Trends in Molecular Medicine 14: 341-350.
32. Sim-Selley LJ, Cassidy MP, Sparta A, Zachariou V, Nestler EJ, et al. (2011) Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens. Neuropharmacology 61: 1470-1476.
33. Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, et al. (2006) An essential role for ΔFosB in the nucleus accumbens in morphine action. Nat Neurosci 9: 205-211.
34. Hyman SE, Malenka RC, (2001) Addiction and the brain: The neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695-703.
35. Koob GF, (2008) A role for Brain Stress System in addiction. Neuron 59: 11-34.
36. Deroche-Gamonet V, Sillaber I, Aouizerate B, Izawa R, Jaber M, et al. (2003) The Glucocorticoid Receptor as a Potential Target to Reduce Cocaine Abuse. J Neurosci 23: 4785-4790.
37. Nestler EJ, (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
38. Laorden ML, Ferenczi S, Pintér-Kübler B, González-Martín LL, Lasheras MC, et al. (2012) Hypothalamic Orexin-A Neurons Are Involved In The Response Of The Brain Stress System To Morphine Withdrawal. PLoS ONE 7: e36871.
39. Navarro-Zaragoza J, Núñez C, Ruiz-Medina J, Laorden ML, Valverde O, et al. (2011) CRF(2) mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats. Br J Pharmacol 162: 851-862.
40. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, et al. (2004) DFosB: a molecular switch for long-term adaptation in the brain. Molecular Brain Research 132: 146-154.
41. Nestler EJ, (2008) Transcriptional mechanisms of addiction: role of DFosB. Phil Trans R Soc B 363: 3245-3255.
42. Crespo JA, Manzanares J, Oliva JM, Corchero J, Garcia-Lecumberri C, et al. (2003) Extinction of cocaine self-administration produces alterations in corticotropin releasing factor gene expression in the paraventricular nucleus of the hypothalamus. Molecular Brain Research 117: 160-167.
43. Maj M, Turchan J, Smialowska M, Przewlocka B, (2003) Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides 37: 105-110.
44. Núñez C, Foldes A, Laorden ML, Milanes MV, Kovács KJ, (2007) Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J Neurochem 101: 1060-1071.
45. Swanson LW, Simmons DM, (1989) Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol 285: 413-435.
46. Makino S, Gold PW, Schulkin J, (1994) Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 657: 141-149.
47. Makino S, Gold PW, Schulkin J, (1994) Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640: 105-112.
48. Viau V, Soriano L, Dallman MF, (2001) Androgens Alter Corticotropin Releasing Hormone and Arginine Vasopressin mRNA Within Forebrain Sites Known to Regulate Activity in the Hypothalamic-Pituitary-Adrenal Axis. Journal of Neuroendocrinology 13: 442-452.
49. Palkovits M, Young WS, Kovács K, Tóth Z, Makara GB, (1998) Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy. Neuroscience 85: 135-147.
50. Smith RJ, Aston-Jones G, (2008) Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 213: 43-61.
51. Sabban EL, Hiremagalur B, Nankova B, Kvetnanský R, (1995) Molecular biology of stress-elicited induction of catecholamine biosynthetic enzymes. Ann N Y Acad Sci 771: 327-338.
52. Roozendaal B, Okuda S, de Quervain DJF, McGaugh JL, (2006) Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 138: 901-910.
53. Rani CSS, Elango N, Wang SS, Kobayashi K, Strong R, (2009) Identification of an Activator Protein-1-Like Sequence as the Glucocorticoid Response Element in the Rat Tyrosine Hydroxylase Gene. Mol Pharmacol 75: 589-598.
54. Hughes P, Dragunow M, (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 47: 133-178.
55. Kovacs GL, Telegdy G, (1988) Hypothalamo-neurohypophyseal neuropeptides and experimental drug addiction. Brain Res Bull 20: 893-895.
56. Kovács KJ, Földes A, Sawchenko PE, (2000) Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J Neurosci 20: 3843-3852.
57. Frenois F, Cador M, Caille S, Stinus L, Le Moine C, (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389.
58. Gold LH, Stinus L, Inturrisi CE, Koob GF, (1994) Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellets implantation in the rat. Eur J Pharmacol 253: 45-51.
59. Paxinos G. and Watson C (2007) The rat brain in stereotaxic coordinates. Amsterdam: Academic Press.
60. Perrotti LI, Weaver RR, Robison B, Renthal W, Maze I, et al. (2008) Distinct patterns of FosB induction in brain by drugs of abuse. Synapse 62: 358-369.